THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Prabhakara Nagareddy to Biomarkers

This is a "connection" page, showing publications Prabhakara Nagareddy has written about Biomarkers.
Connection Strength

0.564
  1. S100 family proteins in inflammation and beyond. Adv Clin Chem. 2020; 98:173-231.
    View in: PubMed
    Score: 0.138
  2. S100A8/A9 in Myocardial Infarction. Methods Mol Biol. 2019; 1929:739-754.
    View in: PubMed
    Score: 0.127
  3. SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr-/- type 1 diabetic mice. Atherosclerosis. 2018 04; 271:166-176.
    View in: PubMed
    Score: 0.119
  4. A novel role for bioactive lipids in stem cell mobilization during cardiac ischemia: new paradigms in thrombosis: novel mediators and biomarkers. J Thromb Thrombolysis. 2014 Jan; 37(1):24-31.
    View in: PubMed
    Score: 0.089
  5. Transient Intermittent Hyperglycemia Accelerates Atherosclerosis by Promoting Myelopoiesis. Circ Res. 2020 09 11; 127(7):877-892.
    View in: PubMed
    Score: 0.035
  6. Chronic sympathetic driven hypertension promotes atherosclerosis by enhancing hematopoiesis. Haematologica. 2019 03; 104(3):456-467.
    View in: PubMed
    Score: 0.031
  7. Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice. Arterioscler Thromb Vasc Biol. 2015 Jan; 35(1):102-10.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES